You're building a healthcare platform in Boston. The architecture has to survive HIPAA, an IRB review, and the day a hospital's IT security team decides to run a penetration test. These are not sequential hurdles — they are simultaneous, overlapping constraints that have to be resolved at the architecture level before you write production code. The team that retrofits HIPAA compliance onto an existing system has a worse story than the team that never considered it; they've already demonstrated the decision-making pattern that makes compliance reviewers nervous.
The specific pressure Boston healthtech founders face: you are selling into institutions — hospitals, health systems, research universities, payers — that have compliance teams and IT security teams whose job is to find the reasons not to approve a new vendor. The clinical champion who wants your product has to bring it through a procurement process designed by people who have seen vendor security incidents. Your architecture is the procurement document.
The Kendall Square ecosystem and its compliance requirements
Kendall Square is one of the densest concentrations of life sciences and biotech capital in the world. Novartis, Pfizer, Takeda, Biogen, Sanofi — major pharma with global R&D operations, a short walk from MIT and Harvard Medical School. The spinout culture is exceptional: companies coming out of MIT, Harvard, Mass General, Dana-Farber, and the Broad Institute arrive with genuine scientific or clinical differentiation and immediately face the challenge of building software that matches the credibility of the science.
The FDA regulatory dimension is specific to this market in a way that isn't true of healthtech ecosystems elsewhere. FDA-regulated software — Software as a Medical Device (SaMD) under 21 CFR Part 11 and the FDA's Software Pre-Certification framework — requires design documentation, risk analysis (often to ISO 14971), software development lifecycle evidence, and change control records. These are not documents you create after the fact. The evidence is generated by the development process itself, which means the development process has to be structured to generate it.
IRB review adds a layer specific to research contexts. Clinical trial software, patient registry platforms, research data platforms — if human subjects data is involved, the IRB will review the data governance architecture as part of the research protocol. Researchers need to be able to describe, in an IRB application, how the software protects participant data, who has access, how de-identification works, and what the data retention and destruction policy is. These are architecture questions answered in a compliance application.
Hospital procurement adds the final layer: IT security questionnaires that are often more rigorous than SOC 2 audits, requiring documented penetration testing, vulnerability disclosure policies, encryption at rest and in transit, business associate agreements, and role-based access control documentation.
Why HIPAA and FDA compliance is architecture, not a checklist
The most common failure mode in Boston healthtech is founders who build a strong product with real clinical value and then discover that their data model, their audit logging implementation, or their access control architecture doesn't satisfy what the compliance requirements actually need.
HIPAA's technical safeguards — access control, audit controls, integrity, transmission security — have specific architectural implications. The audit control requirement means every access to protected health information needs to be logged in a way that can be queried for investigation. If your database access layer doesn't generate those logs at the row level, you either retrofit it (expensive, risky) or you live with a gap in your audit control capability.
FDA 21 CFR Part 11 has specific requirements for electronic records: audit trails that record who changed what and when, user authentication controls, record retention in a format that can be read for the retention period. These are data model decisions. If the data model wasn't designed with 21 CFR Part 11 in mind, the retrofit involves schema changes, which means migration risk on clinical data.
Getting the compliance architecture right from the start is a lower-cost, lower-risk path than getting it wrong and correcting it under procurement pressure.
For a concrete example of how compliance-ready architecture is built from the ground up, see the compliance-ready SaaS engagement: Compliance-ready SaaS architecture.
Why a senior EU team works for Boston regulated builds
The EU context is an advantage in regulated software engineering, not a disadvantage. GDPR has made EU-based engineering teams more fluent in data governance, access control, retention policies, and consent architecture than teams without that exposure. The overlap between GDPR requirements and HIPAA requirements is substantial — data minimization, purpose limitation, right of access, breach notification. A team with production GDPR experience brings the compliance architecture instincts that translate directly to the HIPAA context.
CET to EST is six hours in winter, five in summer. The working overlap from 9am–2pm EST covers the hours when Boston founders are most available for architecture reviews and technical alignment. The async that handles the rest follows the documentation discipline that regulated software development requires anyway.
Keelroot operates senior-only. The engineers scoping your regulated platform have built systems that have gone through compliance reviews — not systems that have been described in compliance documents without corresponding technical reality. The documentation that accompanies the architecture is real documentation: design decisions recorded, risk analysis traceable, data flows mapped.
Is this the right fit?
Boston founders building healthtech, biotech software, or any regulated system where the compliance architecture is a procurement requirement before the commercial relationship begins. The right engagement starts before the architecture is locked — but the value is highest before the first major prospective customer's IT security team asks for documentation that doesn't exist yet.
Budget range: $25k–$200k+ depending on regulatory tier and scope. Fixed architecture engagements or ongoing managed engineering with compliance documentation support. Technical discovery call before any commitment.
Tell us what's actually broken.
We read everything. We reply.